Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,369,000 | 3,223,600 | 2,460,200 | 2,818,600 | 2,380,800 |
| Marketable Securities | 149,400 | 140,400 | 126,100 | 109,100 | 113,100 |
| Receivables | 12,051,700 | 13,079,000 | 10,013,500 | 11,336,200 | 10,363,800 |
| Inventories | 7,459,800 | 6,481,500 | 6,101,800 | 5,772,800 | 4,901,400 |
| Other current assets | 134,600 | 142,200 | 138,600 | 149,500 | 0 |
| TOTAL | $31,415,100 | $30,204,300 | $25,188,800 | $25,727,000 | $23,007,000 |
| Non-Current Assets | |||||
| PPE Net | 16,171,800 | 14,829,400 | 13,624,000 | 12,913,600 | 11,863,200 |
| Investments And Advances | 3,200,200 | 2,877,600 | 3,086,900 | 3,052,200 | 2,691,700 |
| Intangibles | 6,537,300 | 6,636,100 | 6,762,200 | 6,906,600 | 6,781,700 |
| Other Non-Current Assets | 18,282,500 | 17,327,400 | 15,281,600 | 15,406,900 | 13,571,900 |
| TOTAL | $44,191,800 | $41,670,500 | $38,754,700 | $38,279,300 | $34,908,500 |
| Total Assets | $75,606,900 | $71,874,800 | $63,943,500 | $64,006,300 | $57,915,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,886,500 | 2,924,800 | 2,473,700 | 2,598,800 | 2,435,100 |
| Other current liabilities | 19,713,300 | 17,864,300 | 14,472,900 | 16,620,700 | 15,340,900 |
| TOTAL | $24,674,100 | $27,121,200 | $18,598,100 | $27,293,200 | $21,998,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 29,045,400 | 23,730,400 | 24,559,900 | 18,320,800 | 17,923,600 |
| Other Non-Current Liabilities | 7,566,700 | 7,387,700 | 7,888,100 | 7,528,600 | 6,686,300 |
| TOTAL | $36,612,100 | $31,118,100 | $32,448,000 | $25,849,400 | $24,609,900 |
| Total Liabilities | $61,286,200 | $58,239,300 | $51,046,100 | $53,142,600 | $46,608,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 949,316 | 950,426 | 950,405 | 950,165 | 949,307 |
| Common Shares | 593,900 | 594,200 | 594,200 | 593,600 | 593,600 |
| Retained earnings | 13,627,200 | 13,178,000 | 12,553,900 | 10,312,300 | 10,309,900 |
| Other shareholders' equity | -7,207,000 | -7,317,900 | -7,227,200 | -7,248,600 | -6,711,100 |
| TOTAL | $14,320,700 | $13,635,500 | $12,897,400 | $10,863,700 | $11,307,400 |
| Total Liabilities And Equity | $75,606,900 | $71,874,800 | $63,943,500 | $64,006,300 | $57,915,500 |